MultiMorbidity Life-Course Approach To Myocardial Health -A Cardiac Sub-Study of the MRC National Survey of Health and Development (NSHD)

Last updated: July 8, 2022
Sponsor: University College, London
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT05455125
123172
  • All Genders

Study Summary

Background The life course accumulation of overt and subclinical myocardial dysfunction contributes to older age mortality, frailty, disability and loss of independence. The Medical Research Council National Survey of Health and Development (NSHD) is the world's longest running continued surveillance birth cohort providing a unique opportunity to understand life course determinants of myocardial dysfunction as part of MyoFit46-the cardiac sub-study of the NSHD.

Methods and expected results The investigators aim to recruit 550 NSHD participants of approximately 75 years+ to undertake high-density surface electrocardiographic imaging (ECGI) and stress perfusion cardiovascular magnetic resonance (CMR). Through comprehensive myocardial tissue characterization and 4-dimensional flow the investigators hope to better understand the burden of clinical and subclinical cardiovascular disease. Supercomputers will be used to combine the multi-scale ECGI and CMR datasets per participant. Rarely available, prospectively collected whole-of-life data on exposures, traditional risk factors and multimorbidity will be studied to identify risk trajectories, critical change periods, mediators and cumulative impacts on the myocardium.

Conclusion By combining well curated, prospectively acquired longitudinal data of the NSHD with novel CMR-ECGI data and sharing these results and associated pipelines with the CMR community, MyoFit46 seeks to transform our understanding of how early, mid and later-life risk factor trajectories interact to determine the state of cardiovascular health in older age.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • NSHD study member.
  • Who is still alive and agreed to take part in the study.

Exclusion

Exclusion Criteria:

  • Pacemaker.
  • Implantable cardio defibrillator.
  • Atrial fibrillation.
  • Complete heart block.
  • Severe asthma.

Study Design

Total Participants: 550
Study Start date:
July 01, 2020
Estimated Completion Date:
June 30, 2024

Connect with a study center

  • UCL Bloomsbury Centre for Clinical Phenotyping

    London, SW13 0JD
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.